Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriyuki Okada

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 31, 2008
Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartanYoshio Konishi, Takashi Morikawa, Noriyuki Okada, et al.
Diabetes Care|April 14, 2012
Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal diseaseYusuke Sakaguchi, Tatsuya Shoji, Terumasa Hayashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2012
Combined use of vitamin D status and FGF23 for risk stratification of renal outcomeChikako Nakano, Takayuki Hamano, Naohiko Fujii, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 24, 2014
ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathyJunya Teranishi, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2011
Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional studyTakuya Uehata, Naohisa Tomosugi, Tatsuya Shoji, et al.
Bone|March 20, 2012
Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysisChikako Nakano, Takayuki Hamano, Naohiko Fujii, et al.
Journal of Hypertension|August 14, 2008
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuriaAkira Nishiyama, Toshitaka Nakagawa, Hiroyuki Kobori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2012
Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney diseaseKakuya Niihata, Naohisa Tomosugi, Takuya Uehata, et al.
Clinical and Experimental Nephrology|November 11, 2011
Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2012
Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapyIsseki Maeda, Tomoshige Hayashi, Kyoko Kogawa Sato, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 31, 2008
Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartanYoshio Konishi, Takashi Morikawa, Noriyuki Okada, et al.
Diabetes Care|April 14, 2012
Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal diseaseYusuke Sakaguchi, Tatsuya Shoji, Terumasa Hayashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2012
Combined use of vitamin D status and FGF23 for risk stratification of renal outcomeChikako Nakano, Takayuki Hamano, Naohiko Fujii, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 24, 2014
ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathyJunya Teranishi, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2011
Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional studyTakuya Uehata, Naohisa Tomosugi, Tatsuya Shoji, et al.
Bone|March 20, 2012
Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysisChikako Nakano, Takayuki Hamano, Naohiko Fujii, et al.
Journal of Hypertension|August 14, 2008
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuriaAkira Nishiyama, Toshitaka Nakagawa, Hiroyuki Kobori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2012
Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney diseaseKakuya Niihata, Naohisa Tomosugi, Takuya Uehata, et al.
Clinical and Experimental Nephrology|November 11, 2011
Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2012
Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapyIsseki Maeda, Tomoshige Hayashi, Kyoko Kogawa Sato, et al.
Pageof 4